Orthopaedic Trauma Association   Report issue

Academic/Hospital Phase 4
Founded: Rosemont IL United States (1977)

Organization Overview

First Clinical Trial
2017
NCT03289858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Orthopaedic Trauma Association

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fractures, Bone (Phase 4)

Hip Fractures (Phase 4)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thromboembolism (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4